3B Future Health promotes Marianne Bjørdal to Partner


27 January 2022


3B Future Health Ventures is pleased to announce the promotion of our colleague Marianne Bjørdal to Partner. Marianne joined 3B Future Health 3 years ago after a rewarding career as a researcher specialising in metabolism, neuroendocrine signalling and growth control.

Roberto De Ponti, founder and general partner of 3B Future Health Fund, is particularly pleased and proud to elevate an outstanding colleague to Partner in recognition of her success to date. “Marianne has been a valuable addition to our team. Her ability to bridge business and science have been important in building and managing our growing portfolio of biotech start-ups. We believe she has the potential to continue to deliver stellar results for investors and to drive value creation at portfolio companies.”

Prior to joining 3B Future Health, Marianne worked as a researcher for the French National Centre for Scientific Research (CNRS). She is a former Marie Curie Early-Stage Researcher and was awarded the AXA Prize from the French Academy of Science in 2014.

Marianne received an M.Sc. in Molecular Biology from the University of Bergen in Norway, a Ph.D. in Molecular and Cellular Biology from the University of Nice in France and an MBA from the IAE Nice Graduate School of Management, France. She is a former board member of Gain Therapeutics Inc [GANX] and currently serves on the board of NeoPhore Ltd and GenEp Inc.

Get in touch

Thank you for your form submission, we will get in contact with you shortly.